1 Min Read
* A1M PHARMA REPORTS POSITIVE RESULTS FROM ITS GLP TOXICOLOGY STUDY - NOW ABLE TO FINALIZE APPLICATION TO INITIATE CLINICAL STUDIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.